GCOR Genencor International, (MM)

Genencor International, Inc. to Present at the JPMorgan Small Cap Conference PALO ALTO, Calif., Oct. 20 /PRNewswire-FirstCall/ -- Genencor International, Inc. (NASDAQ:GCOR) today announced that the company will present at the JPMorgan Small Cap Conference at 2:50 p.m. EDT on Tuesday, October 26th, 2004 at the Four Seasons in Boston, MA. Raymond Land, senior vice president and chief financial officer of Genencor International, Inc. will provide an overview of the company. An audio webcast of the presentation as well as the associated slide presentation will be available on the homepage at http://www.genencor.com/ during the presentation and will be archived on that same site following the conference. About Genencor Genencor International, Inc. (http://www.genencor.com/) is a diversified biotechnology company that develops and delivers innovative products and services into the health care, agri-processing, industrial and consumer markets. Using an integrated set of technology platforms, Genencor's products deliver innovative and sustainable solutions to improve the quality of life. Genencor traces its history to 1982 and has grown to become a leading biotechnology company, with over $380 million in year 2003 annual revenues. Genencor has principal offices in Palo Alto, California; Rochester, New York; and Leiden, the Netherlands. DATASOURCE: Genencor International, Inc. CONTACT: media, Valerie Tucker, +1-650-846-7571, or investors, Thomas Rathjen, +1-650-846-7500, both of Genencor International, Inc. Web site: http://www.genencor.com/

Copyright